UNH: 10-Q financial filing

unh-20260930 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-Q __________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2026 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 1-10864 __________________________________________________________ UnitedHealth Group Incorporated (Exact name of registrant as specified in its charter) __________________________________________________________ Delaware 41-1321939 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 1 Health Drive 55344 655 New York Avenue NW 20001 Eden Prairie, Minnesota Washington, DC (Address of principal executive offices) (Zip Code) (Address of principal executive offices) (Zip Code) (800) 328-5979 (Registrant’s telephone number, including area code) _________________________________________________________ Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.01 par value UNH New York Stock Exchange Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically